Alphamab Oncology

HKEX:9966.HK

3.87 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Operating Activities:
Net Income -44.896-170.731-39.862-178.413-147.309-145.053-267.364-324.666-103.1-773.955-58.785-208.185-97.892-51.951-37.461-37.461-8.265-8.265-8.265
Depreciation & Amortization 37.29236.76532.35331.91423.27421.72419.37816.01214.1156.7445.0292.9434.4882.0741.6411.6410.1290.1290.129
Deferred Income Tax 002.316-18.40819.72810.4092.616-2.605-11.719-64.20425.210-9.5717.17400000
Stock Based Compensation 1.1149.2464.0468.0745.2184.1034.06512.64120.08678.66712.35622.75622.7560.26300000
Change In Working Capital 3.161-3.40913.2044.5541.971-21.203-1.242-30.111-5.072-14.053-42.278-3.051-8.095-7.437-0.831-0.831-0.163-0.163-0.163
Accounts Receivables -6.03516.424-8.065-0.65-7.234-7.60601.293-1.293-9.051-24.1280-14.639-2.40100000
Change In Inventory 13.584-15.8141.70310.984-17.712-6.906-6.681-11.329-7.074-5.412-13.438-4.7131.454-5.036-0.896-0.896-0.78-0.78-0.78
Change In Accounts Payables 0000000000-1.6620-1.662-0.06400000
Other Working Capital -4.388-4.01919.566-5.7826.917-6.6915.439-20.0753.2950.41-4.7121.6625.0900.0640.0640.6170.6170.617
Other Non Cash Items -42.663-1.074-83.377-20.403-29.18835.86529.127126.805-73.89587.114-26.336129.16334.10830.56813.18313.183-7.991-7.991-7.991
Operating Cash Flow -45.992-129.203-73.636-154.274-146.034-104.564-216.036-199.319-147.861-115.483-110.014-56.374-67.391-26.483-23.469-23.469-16.29-16.29-16.29
Investing Activities:
Investments In Property Plant And Equipment -4.865-14.065-22.119-64.76-64.891-100.655-57.464-45.779-45.043-97.739-73.634-42.843-46.536-26.582-18.28-18.28-2.088-2.088-2.088
Acquisitions Net 0000000000125.5020125.502-0.1500000
Purchases Of Investments 0000000000-287.277-287.277-287.277-12.225-12.225-12.225-8.5-8.5-8.5
Sales Maturities Of Investments 0000000000161.776161.776161.77612.37512.37512.37511.11311.11311.113
Other Investing Activites 42.81152.433-134.356478.127502.2814.92717.463219.568-1,652.429160.362-643.002168.3455.201-4.19318.1318.13-0.525-0.525-0.525
Investing Cash Flow 37.945138.368-156.475413.367437.389-85.735659.999173.789-1,697.47262.623-716.636-168.345-41.335-30.775-18.13-18.130.5250.5250.525
Financing Activities:
Debt Repayment -62.5380-61.7190-111.7580-81.0120-4.3750-40.52900-52.987-16.882-16.882000
Common Stock Issued 0000000000411.547411.547411.5470.0020.0020.002000
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities -4.45-39.557319.348-186.156-12.988288.451-5.561-31.003221.9571,667.683405.369-411.547727.98617.82716.8816.88000
Financing Cash Flow 58.088-39.557257.629-186.156-124.746288.45175.451-31.003217.5821,667.683445.898411.547727.98670.814-58.581-58.5810.50.50.5
Other Information:
Effect Of Forex Changes On Cash 4.165-19.92239.59518.8857.4523.136-2.7171.6610.078-0.6180.3020.027-8.6982.1842.1842.18415.26815.26815.268
Net Change In Cash 54.206067.11391.822174.061101.288516.697-54.872-1,627.6731,614.20595.134308.539443.81723.136158.414158.4140.0030.0030.003
Cash At End Of Period 1,140.1941,136.3021,136.3021,069.189977.367803.306702.018185.321240.1931,867.767253.562466.967466.96723.15158.428158.4280.0140.0140.014